Specialists define and discuss extrapolation, along with the importance of strong data in specific disease states. This is a video synopsis/summary of a panel discussion involving Ryan Haumschild, ...
The final guidance explains some principles for developing biosimilars and establishes some rules about extrapolation across indications for various medical conditions. EMA released final guidance on ...
Extrapolation from pivotal trial data to broader U.S. Food and Drug Administration (FDA)-approved indications is common, according to a study published online April 19 in JAMA Network Open. Daniel ...
Some of the most widely used biologic medicines in oncology have patents about to expire, opening the market to noninnovative versions of these drugs. There are already many examples of price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results